Impact of Variations in Urinary pH on the Pharmacokinetics of LY2140023 and LY404039 in Healthy Subjects.
Latest Information Update: 21 Sep 2026
At a glance
- Drugs Pomaglumetad methionil (Primary)
- Indications Psychotic disorders
- Focus Pharmacokinetics
- Sponsors Denovo Biopharma
Most Recent Events
- 11 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Sep 2011 New trial record